These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6520835)

  • 1. The effect of juvenile inflammatory synovial fluid on in vitro cartilage.
    Silverman ED; Smith RL; Schurman DJ; Miller JJ
    J Rheumatol; 1984 Dec; 11(6):798-803. PubMed ID: 6520835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous secretion of a proteoglycan releasing factor by mononuclear cells in juvenile arthritis.
    Silverman ED; Smith RL; Schurman DJ; Miller JJ
    J Rheumatol; 1987 Jun; 14(3):540-7. PubMed ID: 3498038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble mediators of articular cartilage degradation in juvenile rheumatoid arthritis.
    Smith RL
    Clin Orthop Relat Res; 1990 Oct; (259):31-7. PubMed ID: 2208870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loading-induced changes in synovial fluid affect cartilage metabolism.
    van de Lest CH; van den Hoogen BM; van Weeren PR
    Biorheology; 2000; 37(1-2):45-55. PubMed ID: 10912177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity--another target for chondroprotective intervention.
    Bell MC; Carroll GJ
    J Rheumatol; 2000 Feb; 27(2):332-8. PubMed ID: 10685793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis.
    Kojima T; Mwale F; Yasuda T; Girard C; Poole AR; Laverty S
    Arthritis Rheum; 2001 Jan; 44(1):120-7. PubMed ID: 11212149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of integrative cartilage repair by proteoglycan 4 in synovial fluid.
    Englert C; McGowan KB; Klein TJ; Giurea A; Schumacher BL; Sah RL
    Arthritis Rheum; 2005 Apr; 52(4):1091-9. PubMed ID: 15818696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRG4 exchange between the articular cartilage surface and synovial fluid.
    Nugent-Derfus GE; Chan AH; Schumacher BL; Sah RL
    J Orthop Res; 2007 Oct; 25(10):1269-76. PubMed ID: 17546655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M induces leukocyte infiltration and cartilage proteoglycan degradation in vivo in goat joints.
    Bell MC; Carroll GJ; Chapman HM; Mills JN; Hui W
    Arthritis Rheum; 1999 Dec; 42(12):2543-51. PubMed ID: 10615999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated intra-articular administration of methylprednisolone acetate on articular cartilage in vivo.
    Robion FC; Doizé B; Bouré L; Marcoux M; Ionescu M; Reiner A; Poole AR; Laverty S
    J Orthop Res; 2001 Mar; 19(2):250-8. PubMed ID: 11347698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice.
    de Hooge AS; van de Loo FA; Bennink MB; Arntz OJ; Fiselier TJ; Franssen MJ; Joosten LA; Van Lent PL; Richards CD; van den Berg WB
    Arthritis Rheum; 2003 Jun; 48(6):1750-61. PubMed ID: 12794844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of melanoma antigen gene by cells from inflamed joints in juvenile rheumatoid arthritis.
    McCurdy DK; Tai LQ; Imfeld KL; Schwartz M; Zaldivar F; Berman MA
    J Rheumatol; 2002 Oct; 29(10):2219-24. PubMed ID: 12375337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis.
    De Benedetti F; Pignatti P; Gerloni V; Massa M; Sartirana P; Caporali R; Montecucco CM; Corti A; Fantini F; Martini A
    J Rheumatol; 1997 Jul; 24(7):1403-9. PubMed ID: 9228145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synovial fluid glycosaminoglycan concentration does not correlate with severity of chondropathy or predict progression of osteoarthritis in a canine cruciate deficiency model.
    Myers SL; Brandt KD; Albrecht ME
    J Rheumatol; 2000 Mar; 27(3):753-63. PubMed ID: 10743821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis.
    Saxena N; Aggarwal A; Misra R
    J Rheumatol; 2005 Jul; 32(7):1349-53. PubMed ID: 15996076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide-derived species in synovial fluid from patients with juvenile idiopathic arthritis.
    Lotito AP; Muscará MN; Kiss MH; Teixeira SA; Novaes GS; Laurindo IM; Silva CA; Mello SB
    J Rheumatol; 2004 May; 31(5):992-7. PubMed ID: 15124263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis.
    Xie DL; Hui F; Meyers R; Homandberg GA
    Arch Biochem Biophys; 1994 Jun; 311(2):205-12. PubMed ID: 8203882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypoxic synovial environment regulates expression of vascular endothelial growth factor and osteopontin in juvenile idiopathic arthritis.
    Bosco MC; Delfino S; Ferlito F; Puppo M; Gregorio A; Gambini C; Gattorno M; Martini A; Varesio L
    J Rheumatol; 2009 Jun; 36(6):1318-29. PubMed ID: 19369471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.